22.1% of Premier American Uranium Would Deepen IsoEnergy’s US Exposure

IsoEnergy agreed to swap 387,491 of its shares for Premier American Uranium shares that would lift its stake to about 22.1%, deepening its US exposure.
- IsoEnergy agreed to acquire 13,642,775 Premier American Uranium shares from Sachem Cove Opportunity Fund LP.
- IsoEnergy pays with 387,491 of its own shares at a deemed price of $11.763 each.
- Assuming completion, IsoEnergy would own about 22.1% of Premier American Uranium non-diluted.
- DISA Uranium, 33% owned by IsoEnergy, completed a US$5 million investment in Premier American Uranium at C$0.75 per subscription receipt.
- Closing of the purchase is subject to customary conditions, including approval by the Toronto Stock Exchange.
IsoEnergy (NYSE American: ISOU | TSX: ISO) has agreed to acquire 13,642,775 common shares of Premier American Uranium (PUR) held by Sachem Cove Opportunity Fund LP, paying with 387,491 of its own shares. Assuming completion, IsoEnergy would own about 22.1% of PUR's outstanding shares. The purchase moves Sachem Cove's position to IsoEnergy and adds to IsoEnergy's exposure to US uranium development and exploration, alongside its own portfolio and its stake in DISA Uranium Corporation.
Terms of the Sachem Cove Share Swap
IsoEnergy pays for the PUR shares entirely in its own stock. The 387,491 IsoEnergy shares carry a deemed price of $11.763 each, for aggregate consideration of $4,558,057. PUR will not issue any securities or receive any proceeds from the purchase.
Before the purchase, IsoEnergy owned 7,493,601 PUR shares and warrants to acquire an additional 3,060,127 PUR shares. That was about 7.8% of PUR's outstanding shares on a non-diluted basis and about 10.7% on a partially diluted basis, assuming the exercise of all its warrants. Assuming completion, IsoEnergy would own 21,136,376 PUR shares and the same number of warrants, 3,060,127. On those bases, that is about 22.1% non-diluted and about 24.5% partially diluted.
IsoEnergy is a founding and strategic shareholder of PUR. The PUR shares are being acquired under an exemption from take-over bid rules.

DISA Uranium's Investment in PUR
IsoEnergy's purchase follows DISA Uranium's separate investment in PU R. PUR has completed a US$5 million strategic investment by DISA Uranium in subscription receipts priced at C$0.75 each. That price was a 41.5% premium to PUR's closing share price on September 14, 2026, the last trading day before the investment was announced.
IsoEnergy owns 33% of DISA Uranium, a company formed in a transaction that closed on August 19, 2026. DISA Uranium combines IsoEnergy's Utah uranium portfolio with DISA's remediation and recovery business and its High-Pressure Slurry Ablation technology. That technology is a mechanical process that raises the ore grade before it is sent to a mill. DISA Uranium also has a US Nuclear Regulatory Commission license. Management sees DISA Uranium’s investment as further support behind PUR.
PUR's Place in IsoEnergy's US Portfolio
PUR owns assets in 3 US uranium districts: New Mexico, Wyoming, and Colorado. Its Cebolleta project in New Mexico is at the preliminary economic assessment (PEA) stage and advancing toward near-term development, while PUR is pursuing in-situ recovery exploration in Wyoming. In-situ recovery is a mining method that dissolves uranium underground and pumps the uranium-bearing solution to the surface. PUR was spun out of Consolidated Uranium before Consolidated Uranium merged with IsoEnergy.
The Utah side of IsoEnergy's US exposure comes through DISA Uranium: the Tony M, Daneros, and Rim mines; the Sage Plain and Flatiron projects; remediation sites; and the High-Pressure Slurry Ablation technology. IsoEnergy groups these as its near-term production potential. PUR adds exposure to past production and to current and historical resources. At the November 4, 2026 close, before the purchase was agreed, PUR had a market capitalization of C$31.6 million and IsoEnergy's holding was valued at C$2.5 million. Management regards the recent weakness in PUR's share price as out of step with the value of its development and exploration assets, and as an opportunity to add to the holding.
Chief Executive Officer and Director of IsoEnergy, Philip Williams, traces the company's US holdings back to a single goal:
"The underlying premise here is we want to grow a significant business in US domestic uranium production."
A larger PUR stake would deepen IsoEnergy’s exposure to development at Cebolleta and in-situ recovery exploration in Wyoming.
US Demand & Processing Capacity
The US has only 1 fully licensed, operating conventional uranium mill, Energy Fuels' White Mesa mill. DISA Uranium plans a new domestic processing facility, anchored by the resource scale of the Utah portfolio, which would be the first new US conventional uranium mill in more than 4 decades.
Williams sizes the gap that federal policy is trying to close:
"They're trying to onshore critical mineral production, uranium being one of those. And there's a massive disconnect today between the demand for uranium in the United States, which is about 50 million pounds per year, and production, 2 million pounds."
DISA Uranium's plan also includes consolidating regional deposits to scale its portfolio, alongside the new mill.
What Comes Next for the PUR Stake
Closing of the Sachem Cove purchase is subject to customary conditions, including Toronto Stock Exchange approval of the IsoEnergy share issuance. DISA Uranium's subscription receipts convert into PUR common shares once the escrow release conditions are satisfied or waived. An early warning report on IsoEnergy's purchase will be available under PUR's profile on SEDAR+.
IsoEnergy holds its PUR securities for investment purposes and has no current plans for them. Depending on market conditions, PUR's business and prospects, and other factors, it may acquire more, dispose of some or all of them, or keep them. Assuming completion, IsoEnergy's US exposure would span near-term production, development, and exploration through its own portfolio, DISA Uranium, and PUR.
FAQs (AI-Generated)
Analyst's Notes




































